OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs
Titel:
OP 2.3 – 00117 The EZH2 inhibitor Tazemetostat increases MHC I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs
Auteur:
Gramatica, A. Danesh, A. Miller, I. Weiler, J. Khan, F. Copertino, D. Chukwukere, U. Leyre, L. Jones, B.